PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'FHNW, School for Life Science, Hofackerstr. 30, CH-4132 Muttenz, Switzerland; BÜHLMANN Laboratories AG, Baselstr. 55, CH-4124 Schönenbuch, Switzerland.\', \'FHNW, School for Life Science, Hofackerstr. 30, CH-4132 Muttenz, Switzerland.\', \'BÜHLMANN Laboratories AG, Baselstr. 55, CH-4124 Schönenbuch, Switzerland.\', \'BÜHLMANN Laboratories AG, Baselstr. 55, CH-4124 Schönenbuch, Switzerland;, Email: fb@buhlmannlabs.ch.\', \'FHNW, School for Life Science, Hofackerstr. 30, CH-4132 Muttenz, Switzerland;, Email: thomas.villiger@fhnw.ch.\', \'BÜHLMANN Laboratories AG, Baselstr. 55, CH-4124 Schönenbuch, Switzerland;, Email: cbg@buhlmannlabs.ch.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2533/chimia.2021.446
?:hasPublicationType
?:journal
  • Chimia
is ?:pmid of
?:pmid
?:pmid
  • 34016243
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.434
?:rankingScore_hIndex
  • 51
is ?:relation_isRelatedTo_publication of
?:title
  • Development of a Unique Rapid Test to Detect Anti-bodies Directed Against an Extended RBD of SARS-CoV-2 Spike Protein.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all